Company profile: Doppel Farmaceutici
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing for pharmaceutical and nutritional products, covering formulation, development, manufacturing, packaging, marketing and post-marketing controls. Delivers R&D for formulation/analytical methods, clinical trial batches and regulatory consultancy. Manufactures solids, semi-solids, liquids, sprays, sterile products, injectables, medical devices, soft gelatin capsules, highly potent drugs, and food/effervescent supplements.
Products and services
- Contract Development and Manufacturing: Doppel architects end-to-end services for pharmaceutical and nutritional products, spanning formulation, development, manufacturing, marketing, and post-marketing controls for third parties
- Pharmaceutical Manufacturing: Doppel produces contract-scale formulation, manufacturing, and packaging across solids, semi-solids, liquids, sprays, sterile products, injectables, and medical devices
- R&D Services: Doppel develops clinical-phase formulation and analytical methods, fabricates clinical trial batches, and delivers regulatory affairs consultancy from registration to filing and post-marketing variations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Doppel Farmaceutici
Veranova
HQ: United States
Website
- Description: Provider of research, development, and manufacturing of sophisticated, complex active pharmaceutical ingredients (APIs) for pharmaceutical and biotech industries, applying scientific expertise and diversified talent to create fresh approaches to resolving business issues and enhancing stakeholder value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veranova company profile →
Synteract
HQ: United States
Website
- Description: Provider of full-service contract research organization (CRO) solutions focused on emerging biopharma, supporting biotech and pharmaceutical companies across all phases of drug development with multidisciplinary teams and expertise in oncology, dermatology, general medicine, infectious disease and vaccine, and neuroscience; a Syneos Health company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synteract company profile →
Presidio Medical
HQ: United States
Website
- Description: Provider of a transformational neuromodulation platform and ULF Neuromodulation Therapy, which uses ultra low frequency current waveforms to inhibit pain signals; shown effective in clinical trials for chronic pain without causing paresthesia, enabling remedies for disorders affecting neuronal activity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Presidio Medical company profile →
ApiJect
HQ: United States
Website
- Description: Provider of a medical technology platform enabling scalable manufacturing and fill-finish of prefilled, single-dose injectors using Blow-Fill-Seal aseptic packaging. Offers the Prefilled ApiJect Injector with a pen needle–style hub; technology licensing for BFS mold/device design, development and production support; and design and engineering services for BFS fill-finish of temperature-sensitive biologics and vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ApiJect company profile →
Letoon
HQ: United Kingdom
Website
- Description: Provider of ultrasonic extraction technology to convert vegetable waste and plant matter into high-value nutrients and ingredients, including lycopene recovery from tomato waste, serving the pharmaceutical, nutraceutical, cosmetic, and food sectors. Activities include production of high-value commodities, mergers and acquisitions, and research partnerships with Italian universities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Letoon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Doppel Farmaceutici
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Doppel Farmaceutici
2.2 - Growth funds investing in similar companies to Doppel Farmaceutici
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Doppel Farmaceutici
4.2 - Public trading comparable groups for Doppel Farmaceutici
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →